Optimizing Clinical Decision-Making in Vitiligo

Preview text: Learn evidence-based strategies for managing vitiligo and JAK inhibitor therapy.

Tuesday, Jun 23, 2026 at 5:02 AM EasternActiveCampaign

Integrative Dermatology SymposiumOptimizing Clinical Decision-Making in Vitiligo

Image not available

No image available for this email.

Subject: Optimizing Clinical Decision-Making in Vitiligo
Preview text: Learn evidence-based strategies for managing vitiligo and JAK inhibitor therapy.
From: info@learnskin.com
Brand: Integrative Dermatology Symposium
ESP: ActiveCampaign
Sent: Tue Jun 23, 2026, 5:02 AM ET
Size: 76 KB
Images: 17
Links: 26, 8 of them buttons
Subject length: 47 characters

Against Integrative Dermatology Symposium's usual

Sent in its busiest hour, 5 AM, which holds 76% of its emails. The subject is 47 characters; its average is 59.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid

	Jun 29, 2026 5:02 AM	Better Questions Lead to Better Outcomes
	Jun 27, 2026 10:29 AM	Confidence in Vitiligo Management: Test Your Knowledge!
	Jun 26, 2026 5:02 AM	Where Skin Health Conversations Move Forward
	Jun 23, 2026 5:02 AM	Optimizing Clinical Decision-Making in Vitiligo (this email)
	Jun 19, 2026 5:02 AM	Your Research Deserves a Broader Audience
	Jun 18, 2026 5:02 AM	What could less mean for your patients?
	Jun 15, 2026 5:03 AM	Advancing the Conversation in Skin Health